BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 26, 2024
Home
»
Newsletters
» BioWorld
BioWorld
July 10, 2008
View Archived Issues
Portola Raises $60M in Series C Extension
Portola Pharmaceuticals Inc. raised $60 million in a Series C extension round to drive its two lead cardiovascular product candidates through Phase II clinical trials. (BioWorld Today)
Read More
Study Shows Pipex's Zinc-Based Drug Improved Dry AMD
Read More
Drugs, Vaccines, Surveillance for Influenza All Get Boosts
Read More
SGX Shares Soar on Merger Giving Lilly Technology Boost
Read More
FDA Axing Approvable Letters, Adding Complete Responses
Read More
Other News To Note
Read More
Clinic Roundup
Read More